Effect of ACE inhibitors, calcium channel blockers and their combination on renal and extrarenal structures in renal failure.
Amann
K
K
Department of Pathology, INF 220/221, Heidelberg, Germany.
Törnig
J
J
Nichols
C
C
Zeier
M
M
Mall
G
G
Ritz
E
E
D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use*; D000818:Animals; D001011:Aorta / Q000187:drug effects* / Q000473:pathology; D001160:Arterioles / Q000187:drug effects; D001794:Blood Pressure; D002121:Calcium Channel Blockers / Q000627:therapeutic use*; D002196:Capillaries / Q000187:drug effects; D004359:Drug Therapy, Combination; D006321:Heart / Q000187:drug effects*; D006973:Hypertension / Q000188:drug therapy* / Q000473:pathology / Q000503:physiopathology; D007676:Kidney Failure, Chronic / Q000188:drug therapy* / Q000473:pathology / Q000503:physiopathology; D008297:Male; D009206:Myocardium / Q000473:pathology; D009929:Organ Size; D051381:Rats; D017207:Rats, Sprague-Dawley
D000806:Angiotensin-Converting Enzyme Inhibitors; D002121:Calcium Channel Blockers